GlassScriptPhysician profile
Brian M Burton
NPI 1255453130
$4,807.90
in general payments reported to CMS, 2019-2025
39 companies · $606 in 2025
The $606 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $691 · 2020: $245 · 2021: $978 · 2022: $816 · 2023: $938 · 2024: $532 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,856 · Travel and Lodging: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,855.58 |
| Travel and Lodging | $221.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $601.39 | 2019-2023 | Lo Loestrin Fe, Botox |
| Bayer Healthcare Pharmaceuticals INC. | $344.75 | 2021-2025 | |
| Pfizer INC. | $344.29 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $344.28 | 2021-2025 | |
| Astellas Pharma US INC | $336.91 | 2020-2025 | Veozah, Myrbetriq |
| Intuitive Surgical, INC. | $322.52 | 2019-2023 | Da Vinci Surgical System |
| Biogen, INC. | $276.07 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $241.51 | 2023-2025 | Myfembree |
| Evofem Biosciences, INC. | $191.05 | 2021-2022 | |
| Myovant Sciences INC. | $185.01 | 2021-2022 | |
| Organon LLC | $178.77 | 2021-2025 | Jada System, Nexplanon |
| Exeltis, USA INC. | $166.68 | 2021-2025 | Slynd |
| Gynesonics, INC. | $152.04 | 2021-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Avion Pharmaceuticals | $147.99 | 2019-2022 | |
| Mylan Pharmaceuticals INC. | $82.61 | 2019-2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Burton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.